Author:
Anttinen J,Kautiainen H,Kuopio T
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Anttinen J, Kuopio T, Nykänen M, Torkkeli H, Saari U, Juhola M (2003) Her-2/Neu oncogene amplification and protein over-expression in interval and screen detected breast Cancers. Anticancer Res 23: 4213–4421
2. Brekelmans CT, Peeters PH, Deurenberg JJ, Collette HJ (1995) Survival in interval breast cancer in the DOM screening programme. Eur J Cancer 31A: 1830–1835
3. Burrell HC, Sibbering DM, Wilson ARM, Pinder SE, Evans AJ, Lindsey JY, Elston CW, Ellis IO, Blamey RW, Robertson JFR (1996) Screening interval breast cancers: mammographic features and prognostic factors. Radiology 199: 811–817
4. Crosier M, Scott D, Wilson RG, Griffith CDM, May FEB, Wesley BE (1999) Differences in Ki-67 and c-erbB2 expression between screen detected and true interval breast cancers. Clin Cancer Res 5: 2682–2688
5. Duffy SW, Tabar L, Chen H-H, Holmqvist M, Yen MF, Abdsalah S, Epstein B, Frodis E, Ljungberg E, Hedborg-Melander C, Sundbom A, Tholin M, Wiege M, Akerlund A, Wu HM, Tung TS, Chiu YH, Chiu CP, Huang CC, Smith RA, Rosen M, Stenbeck M, Holmberg M (2002) The impact of organised mammography service screening on breast cancer mortality in seven Swedish counties. A collaborative evaluation. Cancer 95: 458–469
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献